Canopy Growth (NYSE:CGC) and Mannatech (NASDAQ:MTEX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.
Earnings and Valuation
This table compares Canopy Growth and Mannatech’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Canopy Growth||$60.79 million||173.84||-$54.88 million||($0.32)||-142.25|
|Mannatech||$173.56 million||0.24||-$1.78 million||N/A||N/A|
Mannatech has higher revenue and earnings than Canopy Growth.
Volatility and Risk
Canopy Growth has a beta of 4.29, suggesting that its stock price is 329% more volatile than the S&P 500. Comparatively, Mannatech has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500.
This is a breakdown of current recommendations and price targets for Canopy Growth and Mannatech, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Canopy Growth currently has a consensus target price of $55.76, suggesting a potential upside of 22.49%. Given Canopy Growth’s higher probable upside, research analysts clearly believe Canopy Growth is more favorable than Mannatech.
This table compares Canopy Growth and Mannatech’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional and Insider Ownership
11.8% of Canopy Growth shares are held by institutional investors. Comparatively, 15.7% of Mannatech shares are held by institutional investors. 24.7% of Mannatech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Mannatech pays an annual dividend of $2.00 per share and has a dividend yield of 11.6%. Canopy Growth does not pay a dividend. Mannatech has raised its dividend for 2 consecutive years.
Mannatech beats Canopy Growth on 9 of the 13 factors compared between the two stocks.
About Canopy Growth
Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules, and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Mannatech, Incorporated provides wellness solutions. The company develops, markets, and sells nutritional supplements, topical, skin care and anti-aging products, and weight-management products. It markets its products through network marketing channels in the Americas, Europe/the Middle East/Africa, and the Asia/Pacific. The company was founded in 1993 and is headquartered in Coppell, Texas.
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.